A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, called Apt1, using artificial intelligence tools and tested it in in vitro experiments, demonstrating its effectiveness in making tumor cells more vulnerable to chemotherapy drugs.
This article was originally published on MedicalXpress.com

